1Maxwell PH. The HIF pathway in cancer [J]. Semin Cell Dev Biol, 2005,16(4-5) :523-530.
2Huang LE,Gu J ,Schau M ,et al. Regulation of hypoxia-inducible factor 1 alpha is mediated by an 2-dependent degradation domain via the ubiquitin-proteasome pathway[J]. Proc Natl Acad Sci USA, 1998,95 (14) : 7987-7992.
3Giatromanolaki A, Koukourakis MI, Sivridis E, et al.Relation of hypoxia inducible factor 1α and 2α in operable non-small cell lung cancer to angiogenic/molecular profile of turnouts and survival[J].Br J Cancer,2001,85(6):881-890.
4Dykins R, Corbett IP, Henry JA, et al. Long-term survival in breast cancer related to overexpression of the c-erbB-2 oncoprotein :an immunohistochemical study using monoclonal antibody NCL-CB11[J]. J Pathol,1991,163(2) :105-110.
5Shweiki D, Neeman M, Itrin A, et al.Induction of vascular endothelial growth factor expression by hypoxia and by glucose deficiency in multicell spheroids: implications for tumor angiogenesis[J]. Proc Natl Acad Sci USA, 1995,92 (3) : 768-772.
6Ravi R, Mookerjee B, Bhujwalla ZM, et al. Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor lalpha[J]. Genes Dev,2000,14(1) :34-44.
5Chen C, Ridzon DA, Broomer A J, et al. Realtime quantification of microRNAs by stem - loop RT - PCR [ J ]. Nucleic Acids Res, 2005,33 (20) :e179.
6Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real- time quantitative PCR and the 2-aacT method [ J ]. Methods,2001,25 (4) :402 -408.
